Endothelial dysfunction, vascular disease and stroke: The ARTICO study

Cerebrovascular Diseases

Volumn 27, Issue SUPPL. 1, 2009, Pages 25-37

  Roquer, J ^a   Segura, T ^b   Serena, J ^c   Castillo, J ^d  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

Atherosclerosis; Endothelial dysfunction; Ischemic stroke

Indexed keywords

ANGIOTENSIN II; ARGININE; ATORVASTATIN; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIN; LOW DENSITY LIPOPROTEIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ANKLE BRACHIAL INDEX; ARTERY INTIMA PROLIFERATION; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE SEVERITY; DOPPLER FLOWMETRY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART FAILURE; HUMAN; MICROALBUMINURIA; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; STROKE; THROMBOCYTE FUNCTION; VASODILATATION;

ANKLE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; BRAIN ISCHEMIA; CAROTID ARTERIES; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; MULTICENTER STUDIES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; STROKE; ULTRASONOGRAPHY, DOPPLER, COLOR; VASODILATION;

EID: 64149092088     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000200439     Document Type: Conference Paper

References (111)

1. Endemann DH, Schiffrin EL:Endothelial dysfunction. J Am Soc Nephrol 2004;15:1983-1992.
2. Allen JD, Cobb FR, Kraus WE, Gow AJ:Total nitric oxide following testing reflects endothelial function and discriminates health status. Free Radic Biol Med 2006;41:740-747.
3. Castillo J, Rama R, Dávalos A:Nitric oxiderelated brain damage in acute ischemic stroke. Stroke 2000;31:852-857.
4. Ross R:Mechanisms of disease:atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
5. Verma S, Anderson TJ:Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002;105:546-549.
6. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM:Brachial flow-mediated dilation predicts incident cardiovascular events in older adults:the Cardiovascular Health Study. Circulation 2007;115:2390-2397.
7. Verma S, Buchanan MR, Anderson TJ:Endothelial function testing as a biomarker of vascular disease. Circulation 2003;108:2054-2059.
8. Blanco M, Rodríguez-Yáñez M, Sobrino T, Leira R, Castillo J:Platelets, inflammation, and atherothrombotic neurovascular disease:the role of endothelial dysfunction. Cerebrovasc Dis 2005;20(suppl 2):32-39.
9. Faraci FM:Oxidative stress. The curse that underlies cerebral vascular dysfunction? Stroke 2005;36:186-188.
10. Barnes PJ, Karin M:Nuclear factor-kB:a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
11. Mary C, Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Crea-ger MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R:Guidelines for the ultrasound assessment of endothelial-dependent-flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265.
12. Anderson TJ:Prognostic significance of brachial flow-mediated vasodilation. Circulation 2007;115:2373-2375.
13. Anderson TJ, Uehata A, Gerhard MD, et al:Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-1241.
14. Pretnar-Oblak J, Sabovic M, Zaletel M:Associations between systemic and cerebral endothelial impairment determined by cerebrovascular reactivity to L-arginine. Endothelium 2007;14:73-80.
15. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Rönnemaa T, Raitakari OT:Interrelations between brachial endothelial function and carotid intima-media thickness in young adults:the cardiovascular risk in young Finns study. Circulation 2004;110:2918-2923.
16. Yan RT, Anderson TJ, Charbonneau F, Title L, Verma S, Lonn E:Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005;45:1980-1986.
17. Zvan B, Zaletel M, Pogacnik T, Kiauta T:Testing of cerebral endothelium function with L-arginine after stroke. Int Angiol 2002;21:256-259.
18. Armengou A, Hurtado O, Leira R, Obón M, Pascual C, Moro MA, Lizasoain I, Castillo J, Dávalos A:L -arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke:a clinical and experimental study. J Cereb Blood Flow Metab 2003;23:978-984.
19. Chen PL, Wang PY, Sheu WH, Chen YT, Ho YP, Hu HH, Hsu HY:Changes of brachial flow-mediated vasodilation in different-ischemic stroke subtypes. Neurology 2006;67:1056-1058.
20. Vischer UM:Von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006;4:1186-1193.
21. Fichtlscherer S, Rosenberger G, Walter DH, et al:Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000;102:1000-1006.
22. Ridker PM:Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-369.
23. Ridker PM, Stampfer MJ, Rifai N:Novel risk factors for systemic atherosclerosis. JAMA 2001;285:2481-2485.
24. Slowik A, Turaj W, Iskra T, Strojny J, Szczudlik A:Microalbuminuria in nondiabetic patients with acute ischemic stroke:prevalence, clinical correlates, and prognostic significance. Cerebrovasc Dis 2002;14:15-21.
25. Schrader J, Luders S, Kulschewski A, Hammersen F, Zuchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W;MARPLE Study Group:Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension:final results of a prospective long-term study (MARPLE Study). J Hypertens 2006;24:541-548.
26. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, HalléJP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S;HOPE Study Investigators:Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426.
27. Valmadrid CT, Klein R, Moss SE, Klein BE:The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000;160:1093-1100.
28. Cao JJ, Barzilay JI, Peterson D, Manolio TA, Psaty BM, Kuller L, Wexler J, Bleyer AJ, Cushman M:The association of microalbu-minuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly:the Cardiovascular Health Study. Atherosclerosis 2006;187:372-377.
29. Ravera M, Ratto E, Vettoretti S, Viazzi F, Leoncini G, Parodi D, Tomolillo C, Del Sette M, Maviglio N, Deferrari G, Pontremoli R:Microalbuminuria and subclinical cerebro-vascular damage in essential hypertension. J Nephrol 2002;15:519-524.
30. Rodríguez-Yáñez M, Castellanos M, Blanco M, Millán M, Nombela F, Sobrino T, Lizasoain I, Dávalos A, Castillo J:Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology 2006;67:1172-1177.
31. Boos CJ, Lip GY, Blann AD:Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006;48:1538-1547.
32. Makin A, Chung NAY, Silverman SH, Blann A, Lip GY:Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Eur Heart J 2004;25:371-376.
33. Nadar S, Lip GY, Blann AD:Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost 2005;94:707-712.
34. Boos CJ, Lane DA, Karpha M, Beevers DG, Haynes R, Lip GY:Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest 2007:132:1540-1547.
35. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S:Endothelial progenitor cells:new hope for a broken heart. Circulation 2003;107:3093-3100.
36. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S:Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:e1-e7.
37. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC:Human endothelial progenitor cells form type II diabetics exhibit impaired proliferation, adhesion incorporation into vascular structures. Circulation 2002;106:2781-2786.
38. Oliveras A, Soler MJ, Martínez-Estrada OM, Vázquez S, Marco-Feliu D, Vila JS, VilaróS, Lloveras J:Endothelial progenitor cells are reduced in refractory hypertension. J Hum Hypertens 2008;22:183-190.
39. Lau KK, Chan YH, Yiu KH, Li SW, Tam S, Lau CP, Kwong YL, Tse HF:Burden of carotid atherosclerosis in patients with stroke:relationships with circulating endothelial progenitor cells and hypertension. J Hum Hypertens 2007;21:445-451.
40. Werner N, Wassmann S, Ahlers P, Schiegl T, Kosiol S , Link A, Walenta K, Nickenig G:Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007;102:565-571.
41. Sobrino T, Hurtado O, Moro MA, Rodrí-guez-Yáñez M, Castellanos M, Brea D, Moldes O, Blanco M, Arenillas JF, Leira R, Dávalos A, Lizasoain I, Castillo J:The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated w it h good outcome. Stroke 2007;38:2759-2764.
42. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T:Endogenous nitric oxide synthase inhibitor:a novel marker of atherosclerosis. Circulation 1999;99:1141-1146.
43. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Boger R:Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 2002;13:490-496.
44. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, Laaksonen R:Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001;358:2127-2128.
45. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP:Asymmetric dimethylarginine (ADMA):a novel risk factor for endothelial dysfunction:its role in hypercholesterolemia. Circulation 1998;98:1842-1847.
46. Juonala M, Viikari JS, Alfthan G, Marniemi J, Kähönen M, Taittonen L, Laitinen T, Raitakari OT:Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circu lation 2007;116:1367-1373.
47. Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens-Lobenhoffer J, Scalera F, Cooke JP, Fliser D, Bode-Böger SM:ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 2006;37:2024-2029.
48. Wang YX:Do measures of vascular compliance correlate with endothelial function? Curr Diab Rep 2007;7:265-268.
49. Correia ML, Haynes WG:Arterial compliance and endothelial function. Curr Diab Rep 2007;7:269-275.
50. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA:Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function:a prospective study. Circulation 2002;105:1567-1572.
51. Brevetti G, Silvestro A, Schiano V, Chiareillo M:Endothelial dysfunction and cardiovascularrisk prediction in peripheral artery disease:additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003;108:2093-2098.
52. Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C , Sciacca R, Di Tullio M, Boden-Albala B, Sacco R, Homma S:The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007;192:197-203.
53. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA:Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003;41:1769-1775.
54. Fathi R, Haluska B, Isbel N, Short L, Marwick TH:The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004;43:616-623.
55. Frick M, Suessenbacher A, Alber HF, Dichtl W, Ulmer H, Pachinger O, Weidinger F:Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol 2005;46:1006-1010.
56. Chan SY, Mancini GBJ, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A:The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003;42:1037-1043.
57. Rundek T, Hundle R, Ratchford E, Ramas R, Sciacca R, Di Tullio MR, Boden-Albala B, Miyake Y, Elkind MS, Sacco RL, Homma S:Endothelial dysfunction is associated with carotid plaque:a cross-sectional study from the population based Northern Manhattan Study. BMC Cardiovasc Disord 2006;6:35.
58. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'A mbrosio A, Montesanti R, Di Sciascio G:Impaired flow-mediated dilation and risk of restenosis in pat ients undergoing coronary stent implantation. Circulation 2005;111:70-75.
59. Parker BA, Ridout SJ, Procter DN:Age and flow-mediated dilation:a comparison of dilatory responsiveness in the brachial and popliteal arteries. Am J Physiol Heart Circ Physiol 2006;291:H3043-H3049.
60. Landmesser U, Drexler H:Endothelial function and hypertension. Curr Opin Cardiol 2007;22:316-320.
61. Hartge MM, Unger T, Kintscher U:The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 2007;4:84-88.
62. Wilkinson I, Cockcroft JR:Cholesterol, lipids and arterial stiffness. Adv Cardiol 2007;44:261-277.
63. Wilkinson IB, McEniery CM:Arterial stiffness, endothelial function and novel pharmacological approaches. Clin Exp Pharmacol Physiol 2004;31:795-799.
64. Freestone B, Chong AY, Nuttall S, Lip GY:Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation:relationship to plasma von Willebrand factor and soluble E-selectin levels. Thromb Res 2008;122:85-90.
65. Skalidis EI, Zacharis EA,Tsetis DK, Pagoni-dis K, Chlouverakis G, Yarmenitis S, Hamilos M, Manios EG, Vardas PE:Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol 2007;99:1258-1262.
66. Nakamura K, Shimizu H, Katoh H, Sano K, Murakami Y, Hashimoto M:Atrial fibrillation impairs endothelial function of forearm vessels in humans. J Card Fail 2001;7:45-54.
67. Pasqualini L, Marchesi S, Vaudo G, Siepi D, Angeli F, Paris L, Schillaci G, Mannarino E:Association between endothelial dysfunction and major cardiovascular events in peripheral arterial disease. Vasa 2003;32:139-143.
68. Bonetti PO, Lerman LO, Lerman A:Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-175.
69. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A:Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-1664.
70. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F:Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997;129:111-118.
71. Schachinger V, Britten MB, Zeiher A:Impaired epicardial coronary vasoreactivity predicts for adverse cardiovascular events during long-term follow-up. Circulation 2000;101:1899-1906.
72. Suwaidi JA, Hamasaki S, Higano ST, Velianou JL, Araujo NA, Lerman A:Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-954.
73. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J:Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-1342.
74. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ:Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24-30.
75. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D:Soluble adhesion molecules and prediction of coronary heart disease:a prospective study and meta-analysis. Lancet 2001;358:971-976.
76. Huang PH, Chen JW, Lu TM, Yu-An Ding P, Lin SJ:Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. Clin Cardiol 2007;30:135-140.
77. Stenborg A, Terent A, Lind L:Endotheliumdependent vasodilatation in forearm is impaired in stroke patients. J Intern Med 2006;259:569-575.
78. Pretnar-Oblak J, Sabovic M, Sebestjen M, Pogacnik T, Zaletel M:Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. Stroke 2006;37:2540-2545.
79. ChlumskýI, Charvát J:Endothelial dysfunction, distensibility and intima-media thickness and aetiology of stroke. J Int Med Res 2005;33:555-561.
80. 2 and L -arginine in patients with severe internal carotid artery stenosis;pre- and post-surgical evaluation with transcranial Doppler. J Neurol Sci 1999;163:153-158.
81. With NotøAT, Bøgeberg Mathiesen E, Amiral J, Vissac AM, Hansen JB:Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques. Thromb Haemost 2006;96:53-59.
82. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas D, Markus HS:Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126:424-432.
83. Hassan A, Gormley K, O'Sullivan M, Knight J, Sham P, Vallance P, Bamford J, Markus H:Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 2004;35:654-659.
84. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, Tajima K, Daimon M, Kato T:Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 2007;255:27-34.
85. Stenborg A, Kalimo H, Viitanen M, Terent A, Lind L:Impaired endothelial function of forearm resistance arteries in CADASIL patients. Stroke 2007;38:2692-2697.
86. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY:Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation:relationship to stroke risk factors. Circulation 2002;106:1962-1967.
87. Kitayama J, Faraci FM, Lentz SR, Heistad DD:Cerebral vascular dysfunction during hypercholesterolemia. Stroke 2007;38:2136-2141.
88. Beamer NB, Coull BM, Clark WM, Wynn M:Microalbuminuria in ischemic stroke. Arch Neurol 1999;56:699-702.
89. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ:Microalbuminuria and stroke in a British population:the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 2004;255:247-256.
90. Freestone B, Lip GY, Chong AY, Nadar S, Lee KW, Blann AD:Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Thromb Haemost 2005;94:702-706.
91. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW:Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008;39:69-74.
92. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S;REACH Registry Investigators:One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-1206.
93. Cotter G, Cannon CP, McCabe CH, et al:Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes:are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J 2003;145:622-627.
94. Guerrero M, Harjai K, Stone GW, et al:Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database). Am J Cardiol 2005;96:649-654.
95. Roquer J, Ois A, Rodríguez-Campello A, Gomis M, Munteis E, Jiménez-Conde J, Cuadrado-Godia E, Martínez-Rodríguez JE:Atherosclerotic burden and early mortality in acute ischemic stroke. Arch Neurol 2007;64:699-704.
96. Mukherjee D, Yadav JS:Carotid artery intimal-medial thickness:indicator of atherosclerotic burden and response to risk factor modification. Am Heart J 2002;144:753-759.
97. Tsioufis C, Dimitriadis K, Antoniadis D, Stefanadis C, Kallikazaros I:Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens 2004;17:470-476.
98. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV:Use of ankle brachial pressure index to predict cardiovascular events and death:a cohort study. BMJ 1996;313:1440-1444.
99. Heald CL, Fowkes FG, Murray GD, Price JF, on behalf of the Ankle Brachial Index Collaboration:Risk of mortality and cardiovascular disease associated with the ankle-brachial index:systematic review. Atherosclerosis 2006;189:61-69.
100. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB:Mortality and cardiovascular risk across the ankle-arm index spectrum:results from the Cardiovascular Health Study. Circulation 2006;113:388-393.
101. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D:Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-386.
102. Allan PL, Mowbray PI, Lee AJ, Fowkes FG:Relationship between carotid intima-me-dia thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke 1997;28:348-353.
103. Abbott RD, Rodriguez BL, Petrovitch H, Yano K, Schatz IJ, Popper JS, Masaki KH, Ross GW, Curb JD:Ankle-brachial blood pressure in elderly men and the risk of stroke:the Honolulu Heart Program. J Clin Epidemiol 2001;54:973-978.
104. Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PW:The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death:the Framingham Study. Arch Intern Med 2003;163:1939-1942.
105. Modrego PJ, Mainar R, Turull L:Recurrence and survival after first-ever stroke in the area of Bajo Aragon, Spain. A prospective cohort study. J Neurol Sci 2004;224:49-55.
106. Sacco RL, Shi T, Zamanillo MC, Kargman DE:Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community:the Northern Manhattan Stroke Study. Neurology 1994;44:626-634.
107. Johnston SC, Gress DR, Browner WS, Sidney S:Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901-2906.
108. Rothwell PM, Giles MF, Flossmann E, et al:A simple score (ABCD) to identify individuals at high early risk of stroke after a transient ischaemic attack. Lancet 2005;366:29-36.
109. Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabin J:Higher risk of further vascular events among transient ischaemic attack patients with diffusion-weighted imaging acute lesions. Stroke 2004;35:2313-2319.
110. Ois A, Cuadrado-Godia E, Jiménez-Conde J, Gomis M, Rodríguez-Campello A, Martínez-Rodríguez JE, Munteis E, Roquer J:Early arterial study in the prediction of mortality after acute ischemic stroke. Stroke 2007;38:2085-2089.
111. Segura T, Castillo J, Roquer J, Serena J:En nombre de los investigadores del estudio ARTICO. Estudio ARTICO:valor pronóstico de la patología arterial sobre las recurrencias vasculares en pacientes con infarto cerebral no cardioembólico. Neurologia 2007;22:788.